Stay updated on Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.

Latest updates to the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page
- Check5 days agoChange DetectedThe revision tag on the page was updated from v3.6.0 to v3.6.2. This appears to be a minor internal version update rather than a change to study content.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded user-focused sections to aid participation and understanding (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and updated the page revision to v3.6.0, with the Intervention/Treatment heading added. Removed the prior formatting of the Intervention/Treatment heading (Intervention / Treatment) and the older revision label (Revision: v3.5.5).SummaryDifference0.1%

- Check27 days agoChange DetectedThe page now displays a new revision tag 'Revision: v3.5.5' replacing the previous 'Revision: v3.5.4', indicating a content/system revision.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 on the page, indicating a routine update to the page's version metadata.SummaryDifference0.0%

- Check56 days agoChange DetectedThe Taiwan site entry was updated from Taoyuan District, Taiwan to Taoyuan, Taiwan, keeping the same postal code. This clarifies the exact city-level location for that recruitment site.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page's revision tag was updated from v3.5.2 to v3.5.3, indicating a minor version update to the page rendering rather than changes to the study content.SummaryDifference0.0%

Stay in the know with updates to Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.